Evidence map›Paper›PMID 36816816›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2023

A Multifactorial Risk Score System for the Prediction of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.

Dongna Hui, Fang Zhang, Yuanyue Lu, Huiqiang Hao, Shuangshuang Tian, Xiuzhao Fan, Yanqin Liu, Xiaoshuang Zhou, Rongshan Li

Open access · goldAbstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Dongna HuiInstitute of Biomedical Sciences, Shanxi University, Taiyuan, People's Republic of China.ORCID 0000-0003-4331-7027
Fang ZhangKidney Disease Data Center, Shanxi Provincial People's Hospital, Taiyuan, People's Republic of China.
Yuanyue LuDepartment of Nephrology, The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, People's Republic of China.
Huiqiang HaoKidney Disease Data Center, Shanxi Provincial People's Hospital, Taiyuan, People's Republic of China.
Shuangshuang TianKidney Disease Data Center, Shanxi Provincial People's Hospital, Taiyuan, People's Republic of China.
Xiuzhao FanKidney Disease Data Center, Shanxi Provincial People's Hospital, Taiyuan, People's Republic of China.
Yanqin LiuKidney Disease Data Center, Shanxi Provincial People's Hospital, Taiyuan, People's Republic of China.
Xiaoshuang ZhouDepartment of Nephrology, Shanxi Provincial People's Hospital, Taiyuan, People's Republic of China.ORCID 0000-0002-9401-7887
Rongshan LiInstitute of Biomedical Sciences, Shanxi University, Taiyuan, People's Republic of China.
Shanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: In-depth investigations of risk factors for the identification of diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) are rare. We aimed to investigate the risk factors for developing DKD from multiple types of clinical data and conduct a comprehensive risk assessment for individuals with diabetes. Methods: We carried out a case-control study, enrolling 958 patients to identify the risk factors for developing DKD in T2DM patients from a database established from inpatient electronic medical records. Multivariable logistic regression was applied to develop a prediction model and the performance of the model was evaluated using the area under the curve (AUC) and calibration curve. A multifactorial risk score system was established according to the Framingham Study risk score. Results: DKD accounted for 34.03% of eligible patients in total. Twelve risk factors were selected in the final prediction model, including age, duration of diabetes, duration of hypertension, fasting blood glucose, fasting C-peptide, insulin use, systolic blood pressure, low-density lipoprotein, γ-glutamyl transpeptidase, platelet, uric acid, and thyroid stimulating hormone; and one protective factor, serum albumin. The prediction model showed an AUC of 0.862 (95% Confidence Interval (CI) 0.834-0.890) with an accuracy of 81.5% in the derivation dataset and an AUC of 0.876 (95% CI 0.825-0.928) in the validation dataset. The calibration curves were excellent and the estimated probability of DKD was more than 80% when the cumulative score for risk factors reached 17 points. Conclusion: Newly recognized risk factors were applied to assess the development of DKD in T2DM patients and the established risk score system was a reliable and feasible tool for assisting clinicians to identify patients at high risk of DKD.

Indexed as

diabetic kidney diseasemultifactorialprediction modelrisk factorstype 2 diabetes

Identifiers

PMID36816816
PMCPMC9928569
OpenAlexW4319787372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.